Avidity Biosciences
RNA
#2580
Rank
ยฃ4.33 B
Marketcap
ยฃ36.64
Share price
0.57%
Change (1 day)
672.49%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of June 2024 : ยฃ1.00 Billion

According to Avidity Biosciences's latest financial reports the company has ยฃ1.00 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ0.46 B-7.43%
2022-12-31ยฃ0.50 B68.03%
2021-12-31ยฃ0.30 B24.8%
2020-12-31ยฃ0.24 B233.78%
2019-12-31ยฃ72.12 M2862.87%
2018-12-31ยฃ2.43 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.84 B-15.84%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.22 M-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.12 B 12.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.28 B-71.08%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.23 B-76.53%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.47 B 446.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.31 B 230.91%๐Ÿ‡ฌ๐Ÿ‡ง UK